Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study
Leonora S. F. Boogerd(Leiden University Medical Center), Charlotte E.S. Hoogstins(Leiden University Medical Center), Dennis P. Schaap(Radboud University Nijmegen), Miranda Kusters(Leiden University Medical Center), Henricus J.M. Handgraaf(Leiden University Medical Center), Maxime J.M. van der Valk(Leiden University Medical Center), Denise E. Hilling(Leiden University Medical Center), Fabian A. Holman(Leiden University Medical Center), Koen Peeters(Leiden University Medical Center), J. Sven D. Mieog(Leiden University Medical Center), Cornelis J.�H. van de Velde(Leiden University Medical Center), Arantza Fariña Sarasqueta(Leiden University Medical Center), Ineke van Lijnschoten(PAMM), Bérénice Framery(Surgimab (France)), André Pèlegrin(Université de Montpellier), Marian Gutowski(Institut Regional du Cancer de Montpellier), Simon W. Nienhuijs(Radboud University Nijmegen), Ignace H. J. T. de Hingh(Radboud University Nijmegen), Grard A. P. Nieuwenhuijzen(Catharina Ziekenhuis), H.J.T. Rutten(Catharina Ziekenhuis), Françoise Cailler(Surgimab (France)), Jacobus Burggraaf(Centre for Human Drug Research), Alexander L. Vahrmeijer(Leiden University Medical Center)
Cited by 196Open Access